POLA-R-CHP in the First-line Treatment of Transformed DLBCL
POLA-R-CHP in the First-line Treatment of Transformed DLBCL
Recruiting · NCT06743945 · Registry updated 2025-02-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| POLA-R-CHP in the First-line Treatment of Transformed DLBCL | Transformed Lymphoma | Recruiting | Phase 2 | 2025-02-25 | NCT06743945 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 257 |